JEWISH TIME PODCAST JEWISH TIME PODCAST SUBSCRIBE TODAY SUBSCRIBE TODAY
search
Bispecific T-cell Engager therapy
Dr. Trevor Feinstein, physician with the Piedmont Cancer Institute.
January 14, 2026, 10:34 am
BiTE Therapy Offers Hope for Cancer Treatment
In Small Cell Lung Cancer, the BiTE therapy tarlatamab targets DLL3, a protein that is highly expressed on small cell lung cancer cells but has minimal expression in normal tissues.
By Sasha Heller
Load More